Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
  • 10/31/2025Roche Strikes Over $1B Global Licensing Deal with Qyuns Therapeutics
  • 10/31/2025Longwood Biopharma Secures Series B+ Funding to Accelerate Innovative ...
  • 10/31/2025Bayer to Divest Avelox Assets to HSG in Deal Valued up to €260 Millio...
  • 10/31/2025Asia Regenerative Medicine Completes Series A Funding
  • 10/29/2025Pharmaron to Acquire Biortus in China
  • 10/29/2025Immunofoco Raises Series B+ Funding to Advance CAR-T Platforms for Sol...
  • 10/28/2025Over 400 Companies Join China's 11th Round of VBP
  • 10/27/2025AstraZeneca Unveils Three Major Initiatives in China
  • 10/27/2025CytoCares Raises CNY 68M in Series A++ Round Led by Tellgen
  • 10/27/2025Taiho Secures Japan Rights to Haihe’s PI3Kα Inhibitor Risovalisib
  • 10/27/2025Kite Strikes $1.5B Cell Therapy Deal With Pregene amid Industry Pullba...
  • 10/24/2025Biokin Passes HKEX Hearing, Poised for Hong Kong Listing
  • 10/24/2025Starna Thera Raises $44M in Series B to Advance RNA-Based Therapies
  • 10/22/2025Samsung Bioepis and Phrontline Forge Partnership to Co-Develop Next-Ge...
  • 10/22/2025Innovent and Takeda Ink $11.4B Oncology Alliance
  • 10/21/2025Riltide Completes Seed Financing to Advance AI-Driven Autoimmune Thera...
  • 10/21/2025Sunnovo Invests in Byterna to Advance Circular mRNA
  • 10/17/2025Gilead's Kite Strikes Up to $1.64B In Vivo CAR-T Deal with China's Pre...
  • 10/17/2025Dianthus Secures Exclusive Global Rights to DNTH212 from China's Leads...
  • 10/17/2025Roche Expands Oncology Pipeline Thru Global Licensing Deal with Hansoh...
  • 10/17/2025I-Mab to Rebrand as NovaBridge Biosciences and Pursue Hong Kong IPO
  • 10/16/2025NHC Holds High-Level Meetings with Abbott and Roche to Advance Healthc...
  • 10/16/2025Kailera Launches with $600M Series B to Advance GLP-1 Portfolio Acqui...
  • 10/16/2025Xuanzhu Bio Soars on Hong Kong Debut After Highly Oversubscribed IPO
  • 10/15/2025Pfizer CEO Calls for Greater U.S.–China Collaboration in Biopharma In...
  • 10/13/2025Huadao Secures Over CNY 100M in Series D+2 Financing to Advance CAR-T ...
  • 10/13/2025AviadoBio and UgeneX Enter Exclusive Option-License Deal to Develop Op...
  • 10/13/2025Huadao Bio Secures Over CNY 100M in Series D+2 Financing
  • 10/13/2025CF PharmaTech Soars 161% on Hong Kong IPO Debut
  • 10/13/2025Eccogene Files for Hong Kong IPO
  • Page:13/26 Total number of articles:765: [First][<<] [11] [12] [13] [14] [15] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group